🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

SGO Bridges - Impressive ground-breaking research career building initiative!

Hold for my upcoming #SGOBRIDGES phase II trial that moves raf/mek/fak inhibition + hormonal blockade to the FRONT-LINE in low grade serous #ovariancancer Expected to start enrolling Memorial Sloan Kettering Cancer Center in the next few weeks 👍

Green is the new black 🍀🍀

Moving the needle on fertility preservation in #endometrialcancer : molecular data can refine our approach!

Amazing experience learning from and working with Claire Friedman MD Dmitriy Zamarin MD PhD — so much to still discover about the immune system and GYN cancer! Read all about our study in Nature Medicine

Excellent read by the talented Tiffany Sia MD!

My “out of office” starting off a little differently than anticipated… All is well and first vacation in a year begins NOW. Great flight crew support and medical kit Delta!

Thank you IJGC for featuring our study on caring for young patients with #endometrialcancer MSKCC Team Uterus

Podcast “debut” with IJGC on our work on ovarian preservation in patients with #endometrialcancer. Always a fun time with Pedro T Ramirez and Jenny Mueller MD

Thrilled to participate in the editorial process, learn from the greats David Cohn, MD, MBA and work to bring forward advancements in GYN cancer care!

Newly arrived Winship gynecologic oncologist Beryl Manning-Geist, MD, kicks off the next session with a talk on targeted and hormone therapy options for treating low-grade epithelial ovarian cancer. #DDHO2024

A wonderful gynecologic cancer session comes to a close with a panel discussion and patient case presentation with all of our speakers. #DDHO2024

Antibody drug conjugates are an exciting new therapy, but so far targeting folate receptor + ovarian cancer is limited to high grade. Here, we show that low grade ovarian cancers have the same % of folate receptor positivity. Next up: see if these treatments benefit patients!

Had a wonderful time joining Tufts ObGyn Residency Program on behalf of Emory Gyn Ob to kick off this year’s Tufts OB/GYN grand rounds and talking about #fertility in #endometrialcancer

Our newest editorial is out now—bravo to #SENECA investigators for their collaborative effort. Excited to see what we can do with this database to improve our clinical care!

Excited to be named an early career new investigator by NRG oncology! Can’t wait to bring more of these #clinicaltrials to our patients at Winship Cancer Institute of Emory University Emory Gyn Ob nrgoncology.org/Home/News/Post…

My better half, Ryan Langdale of Chartis, quoted in the The Wall Street Journal on consolidation in the cancer industry. wsj.com/health/pharma/…

Still beaming from the magic that was the TCS New York City Marathon in the city I love so very much 🏃🏼‍♀️🏃🏼‍♀️🏃🏼‍♀️

It’s standing room only at Winship Cancer Institute of Emory University combined GYN onc and surg onc journal club as we refine our evidence-based #HIPEC protocol for #ovariancancer patients at Emory Susan C. Modesitt, MD Jennifer Scalici Sarah Dilley Seth Concors (he/him)

A privilege to provide commentary in @GynOncJnls on how we leverage the folate receptor to treat gynecologic malignancy. It’s time to outsmart cancer! Winship Cancer Institute of Emory University pubmed.ncbi.nlm.nih.gov/39667863/